Cargando…

Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats

Vascularized periosteal flaps are used for complex cases if the reconstruction of large bone defects is necessary in modern trauma and orthopedic surgery. In this study, we combined this surgical procedure with β-TCP scaffold and mesenchymal stem cells (MSCs) + endothelial progenitor cells (EPCs) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Nau, Christoph, Henrich, Dirk, Seebach, Caroline, Schröder, Katrin, Barker, John H., Marzi, Ingo, Frank, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360440/
https://www.ncbi.nlm.nih.gov/pubmed/28259928
http://dx.doi.org/10.3892/ijmm.2017.2901
_version_ 1782516605109927936
author Nau, Christoph
Henrich, Dirk
Seebach, Caroline
Schröder, Katrin
Barker, John H.
Marzi, Ingo
Frank, Johannes
author_facet Nau, Christoph
Henrich, Dirk
Seebach, Caroline
Schröder, Katrin
Barker, John H.
Marzi, Ingo
Frank, Johannes
author_sort Nau, Christoph
collection PubMed
description Vascularized periosteal flaps are used for complex cases if the reconstruction of large bone defects is necessary in modern trauma and orthopedic surgery. In this study, we combined this surgical procedure with β-TCP scaffold and mesenchymal stem cells (MSCs) + endothelial progenitor cells (EPCs) as a tissue engineering approach to obtain optimum conditions for bone healing in rats. A critical size femoral defect was created in 80 rats allocated into 4 groups. Defects were treated according to the following protocol: i) vascularized periosteal flap alone; ii) vascularized periosteal flap + β-TCP scaffold; iii) vascularized periosteal flap + β-TCP scaffold + ligated vascular pedicle; and ii) vascularized periosteal flap + β-TCP scaffold + MSCs/EPCs. After 8 weeks, femur bones were extracted and analyzed for new bone formation, vascularization, proliferation and inflammatory processes and strength. Bone mineral density (BMD) and biomechanical stability at week 8 were highest in group 4 (flap + β-TCP scaffold + MSCs/EPCs) compared to all the other groups. Stability was significantly higher in group 4 (flap + β-TCP scaffold + MSCs/EPCs) in comparison to group 3 (ligated flap + β-TCP scaffold). BMD was found to be significantly lower in group 3 (ligated flap + β-TCP scaffold) compared to group 1 (flap) and group 4 (flap + β-TCP scaffold + MSCs/EPCs). The highest density of blood vessels was observed in group 4 (flap + β-TCP + MSCs/EPCs) and the values were significantly increased in comparison to group 3 (ligated flap), but not to group 1 (flap) and group 2 (flap + β-TCP). The highest amounts of proliferating cells were observed in group 4 (flap + β-TCP scaffold + MSC/EPCs). The percentage of proliferating cells was significantly higher in group 4 (flap + β-TCP scaffold + MSCs/EPCs) in comparison to all the other groups after 8 weeks. Our data thus indicate that critical size defect healing could be improved if MSCs/EPCs are added to β-TCP scaffold in combination with a periosteal flap. Even after 8 weeks, the amount of proliferating cells was increased. The flap blood supply is essential for bone healing and the reduction of inflammatory processes.
format Online
Article
Text
id pubmed-5360440
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-53604402017-04-10 Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats Nau, Christoph Henrich, Dirk Seebach, Caroline Schröder, Katrin Barker, John H. Marzi, Ingo Frank, Johannes Int J Mol Med Articles Vascularized periosteal flaps are used for complex cases if the reconstruction of large bone defects is necessary in modern trauma and orthopedic surgery. In this study, we combined this surgical procedure with β-TCP scaffold and mesenchymal stem cells (MSCs) + endothelial progenitor cells (EPCs) as a tissue engineering approach to obtain optimum conditions for bone healing in rats. A critical size femoral defect was created in 80 rats allocated into 4 groups. Defects were treated according to the following protocol: i) vascularized periosteal flap alone; ii) vascularized periosteal flap + β-TCP scaffold; iii) vascularized periosteal flap + β-TCP scaffold + ligated vascular pedicle; and ii) vascularized periosteal flap + β-TCP scaffold + MSCs/EPCs. After 8 weeks, femur bones were extracted and analyzed for new bone formation, vascularization, proliferation and inflammatory processes and strength. Bone mineral density (BMD) and biomechanical stability at week 8 were highest in group 4 (flap + β-TCP scaffold + MSCs/EPCs) compared to all the other groups. Stability was significantly higher in group 4 (flap + β-TCP scaffold + MSCs/EPCs) in comparison to group 3 (ligated flap + β-TCP scaffold). BMD was found to be significantly lower in group 3 (ligated flap + β-TCP scaffold) compared to group 1 (flap) and group 4 (flap + β-TCP scaffold + MSCs/EPCs). The highest density of blood vessels was observed in group 4 (flap + β-TCP + MSCs/EPCs) and the values were significantly increased in comparison to group 3 (ligated flap), but not to group 1 (flap) and group 2 (flap + β-TCP). The highest amounts of proliferating cells were observed in group 4 (flap + β-TCP scaffold + MSC/EPCs). The percentage of proliferating cells was significantly higher in group 4 (flap + β-TCP scaffold + MSCs/EPCs) in comparison to all the other groups after 8 weeks. Our data thus indicate that critical size defect healing could be improved if MSCs/EPCs are added to β-TCP scaffold in combination with a periosteal flap. Even after 8 weeks, the amount of proliferating cells was increased. The flap blood supply is essential for bone healing and the reduction of inflammatory processes. D.A. Spandidos 2017-04 2017-02-21 /pmc/articles/PMC5360440/ /pubmed/28259928 http://dx.doi.org/10.3892/ijmm.2017.2901 Text en Copyright: © Nau et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Nau, Christoph
Henrich, Dirk
Seebach, Caroline
Schröder, Katrin
Barker, John H.
Marzi, Ingo
Frank, Johannes
Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title_full Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title_fullStr Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title_full_unstemmed Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title_short Tissue engineered vascularized periosteal flap enriched with MSC/EPCs for the treatment of large bone defects in rats
title_sort tissue engineered vascularized periosteal flap enriched with msc/epcs for the treatment of large bone defects in rats
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360440/
https://www.ncbi.nlm.nih.gov/pubmed/28259928
http://dx.doi.org/10.3892/ijmm.2017.2901
work_keys_str_mv AT nauchristoph tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT henrichdirk tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT seebachcaroline tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT schroderkatrin tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT barkerjohnh tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT marziingo tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats
AT frankjohannes tissueengineeredvascularizedperiostealflapenrichedwithmscepcsforthetreatmentoflargebonedefectsinrats